Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 1 hour 1 min ago

Zejula successful in advanced ovarian cancer

02/10/2019
GlaxoSmithKline presented the results at the ESMO Congress.

Novartis announces positive asthma results

02/10/2019
Marketing applications for the treatments are currently being reviewed by the EMA.

Novartis presents positive asthma results at ESMO

02/10/2019
Marketing applications for the treatments are currently being reviewed by the EMA.

Survey reveals women with cancer feel ‘stigmatised’

01/10/2019
The report found that there is still significant “room for improvement to promote understanding of all cancers and their risk factors."

Continued success for Lynparza in ovarian cancer

01/10/2019
The drug improved progression-free survival time to a median of 22.1 months, compared to 16.6 months.

Lynparza bags positive prostate cancer results

01/10/2019
The drug more than doubled median radiographic progression-free survival.

Invokana bags FDA approval

01/10/2019
The treatment has been approved to reduce the risk of hospitalisation for heart failure in certain patients with type II diabetes.

Report shows no-deal Brexit is still a “highly uncertain environment”

30/09/2019
The National Audit Office report states that despite the extensive preparations, there still remains a “significant amount to do before 31 October.”

NICE guidance could avert 1,000+ neonatal admissions

30/09/2019
The guidance could lead to as many as 634 fewer emergency caesarean sections and 1,308 fewer neonatal admissions in England, per year.

GSK announces positive real world data for Nucala

30/09/2019
The study is the first prospective global real-world study of a biologic treatment in patients with severe eosinophilic asthma.

Suliqua launches in UK

30/09/2019
The approval is based on two phase III studies, LixiLan-O and LixiLan-L.

Lenvima, Keytruda combo shows anti-tumour activity

30/09/2019
Following the positive results of the trial, the companies have announced that the LEAP-001 Phase III study is now underway.

Entyvio beats Humira in head-to-head ulcerative colitis trial

27/09/2019
Results offer new insight to support treatment decisions, Takeda says

Gov't pledges overhaul of cancer screening

27/09/2019
Hospitals to get upgraded machines under the plans

RSPH calls for swift action on declining child vaccine coverage

27/09/2019
The government must follow through with its commitment to deliver a comprehensive strategy this Autumn, to address the gaps in vaccination uptake, the Society says

Pfizer UK removes sales incentives for anti-infectives

27/09/2019
The move comes under the firm's commitment to fight antimicrobial resistance

Industry shoots down Labour's plans to tackle 'extortionate' drug prices

26/09/2019
Labour intends to create state-owned generic drugs company

Positive PhIII data for Jazz sleep disorder drug

26/09/2019
JZP-258 achieved primary and key secondary endpoints showing significant differences in weekly number of cataplexy attacks and Epworth Sleepiness Scale scores compared to placebo

NICE backs womb op for babies with spina bifida

26/09/2019
Procedure carried out on unborn babies with spina bifida could improve their neurodevelopment

Novartis' Aimovig unlikely to be NHS funded for migraine

26/09/2019
NICE has published final draft guidelines rejecting the drug in this setting

Pages

X